Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Regeneron Pharmaceuticals
(NQ:
REGN
)
1,034.15
+7.60 (+0.74%)
Streaming Delayed Price
Updated: 11:11 AM EDT, Jun 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Regeneron Pharmaceuticals
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
37
38
Next >
Vir Soars As Its Addition To SmallCap 600 Helps Wipe Out Recent Covid Volatility
March 30, 2022
Vir Biotechnology remains under pressure despite its looming addition to a new index.
Via
Investor's Business Daily
Biotech Funds and ETFs Continue to Lag
March 28, 2022
It’s no secret that market sectors driving inflation are leading the market. With the US economy still strong and the War in Ukraine limiting supply of nat gas and raw materials, producer costs are...
Via
Talk Markets
Overview Of Value Stocks In The Healthcare Sector
March 28, 2022
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
Regeneron-Sanofi's Dupixent Significantly Improved Signs, Symptoms In Chronic Itchy Skin Disease
March 28, 2022
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA (NASDAQ: SNY) have presented
Via
Benzinga
Acadia Pharmaceuticals Stock Shows Market Leadership With Jump To 91 RS Rating
March 25, 2022
Acadia Pharmaceuticals stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, rising from 88 to 91.
Via
Investor's Business Daily
How Rivals Merck, Bristol Myers Benefit From Eli Lilly's FDA Snag
March 24, 2022
The Food and Drug Administration on Thursday rejected a lung cancer drug Eli Lilly tested only in China, but LLY stock inched higher.
Via
Investor's Business Daily
How do Biotechnology Funds and ETFs Perform Over Five Years?
March 21, 2022
Biotech investing can be difficult for short-term traders but can offer good returns over five years if balanced with other healthcare positions like the XLV.
Via
Talk Markets
Regeneron Pharmaceuticals Inc. Climbs To Annual-High Share Price
March 21, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Shares of Regeneron Pharmaceuticals Inc...
Via
Benzinga
Regeneron Pharmaceuticals Inc. (REGN) Climbs to Annual-High Share Price
March 21, 2022
Via
Investor Brand Network
Regeneron Pharmaceuticals Inc. (REGN) Climbs to Annual-High Share Price
March 21, 2022
Via
Investor Brand Network
Matinas BioPharma Updates — Q4 2021 Earnings And Conference Call Recap
March 21, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
Fed Rate Hike Rallies Stocks
March 17, 2022
The Federal Reserve led by Jerome Powell hiked interest rates for the first time in three years causing stocks to rally.
Via
Talk Markets
Best Biotech Stocks To Buy In 2022
March 15, 2022
Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and...
Via
Talk Markets
J.B. Hunt, Costco Lead Five Stocks Nearing Buy Points
March 12, 2022
J.B. Hunt and Costco are holding up near buy points in a tough market.
Via
Investor's Business Daily
Markets Fall Again As Russia-Ukraine War Erodes Investor Sentiment
March 11, 2022
U.S. Indices finished lower Friday amid continued uncertainty from the Russia-Ukraine conflict. The Nasdaq composite finished lower by 2.18% to 12,843; The Invesco QQQ Trust...
Via
Benzinga
Upcoming Stock Splits 2022: 20 Companies That Could Follow Amazon’s Lead
March 10, 2022
We're taking a gander at more companies that could follow Amazon's (AMZN) lead with potential upcoming stock splits in 2022.
Via
InvestorPlace
BioNTech, Regeneron To Evaluate FixVac-Based Cancer Vaccine/Libtayo Combo In NSCLC
March 08, 2022
BioNTech SE (NASDAQ: BNTX) has expanded its strategic collaboration with Regeneron Pharmaceuticals Inc (NASDAQ: REGN) to its FixVac candidate BNT116...
Via
Benzinga
WHO Conditionally Recommends Merck's COVID-19 Antiviral Pill For High-Risk Patients
March 03, 2022
A World Health Organization (WHO) panel has backed the use of Merck & Co Inc's (NYSE: MRK) COVID-19 antiviral pill for high-risk patients. The expert...
Via
Benzinga
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
March 01, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine...
Via
Benzinga
Intellia Shares Updated Data On Gene Editing Durability In Rare Disease
March 01, 2022
Eight months after delivering promising biomarker data from one of the first CRISPR trials, Intellia Therapeutics Inc (NASDAQ: NTLA) presented additional data...
Via
Benzinga
Intellia Therapeutics Crashes As Patent Decision Clouds CRISPR Gene-Editing Test
February 28, 2022
Intellia Therapeutics said its gene-editing drug lowered levels of a troublesome protein.
Via
Investor's Business Daily
Does the FDA Rollback Of Regeneron And Eli Lilly COVID Treatment EUAs Signal A Need To Look Beyond Monoclonal Antibodies? NanoViricides, Inc. Looks To Meet This Need With A New Approach
February 28, 2022
Photo credit: Marcelo Leal and Kate Hliznitsova on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended...
Via
Benzinga
3 Moonshot Stocks Insiders Are Buying. What Do They Know?
February 25, 2022
Biotech stocks aren't a sure thing, but one good sign is insiders buying up shares. These three all offer that enticing feature.
Via
InvestorPlace
7 Low Volatility Stocks to Buy Right Now for Steady Returns
February 24, 2022
A great way to find low volatility stocks is to look for a beta that's less than 1.0. Here are seven to buy as market turbulence increases.
Via
InvestorPlace
KOD Stock Alert: Why Is Kodiak Sciences Plunging 80% Today?
February 23, 2022
Disappointing drug trial results have sent Kodiak Sciences and shares of KOD stock plunging more than 80% in today's trading session.
Via
InvestorPlace
S&P 500 Slips Further into Correction Territory as Stocks Give Up Gains
February 23, 2022
Stocks have pulled back from this morning's gains, amid the ongoing Russia-Ukraine border crisis, with all three benchmarks looking to extend their losing streaks.
Via
Talk Markets
Kodiak Stock Pummeled After Attempt To Improve On Regeneron's Blockbuster Backfired
February 23, 2022
Kodiak hoped a less frequent dosing plan would benefit patients with an eye disease.
Via
Investor's Business Daily
Why Kodiak Sciences Shares Are Plunging Today
February 23, 2022
Kodiak Sciences Inc (NASDAQ: KOD) has announced topline results from its Phase 2b/3 trial evaluating KSI-301 in treatment-naïve subjects with neovascular (wet) age-...
Via
Benzinga
Is Moderna the Next Gilead or the Next Regeneron?
February 22, 2022
MRNA stock is seen purely as a Covid-19 play. Until Moderna can prove it's not a one-hit wonder, shares are likely to remain depressed.
Via
InvestorPlace
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...
Via
Benzinga
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.